In conclusion, our study suggests that ITGA5 is upregulated in HNSCC and associated with poor prognosis; functional studies indicate ITGA5 promotes OSCC proliferation and metastasis via SNAI2, indicating that ITGA5 may be a potential therapeutic target for OSCC. This evidence concerns the gene ITGA5 and head and neck squamous cell carcinoma.